JP5549547B2 - 筋細胞の出力装置及び筋細胞の出力評価方法 - Google Patents
筋細胞の出力装置及び筋細胞の出力評価方法 Download PDFInfo
- Publication number
- JP5549547B2 JP5549547B2 JP2010247914A JP2010247914A JP5549547B2 JP 5549547 B2 JP5549547 B2 JP 5549547B2 JP 2010247914 A JP2010247914 A JP 2010247914A JP 2010247914 A JP2010247914 A JP 2010247914A JP 5549547 B2 JP5549547 B2 JP 5549547B2
- Authority
- JP
- Japan
- Prior art keywords
- muscle
- output device
- contraction
- cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000663 muscle cell Anatomy 0.000 title claims description 96
- 238000011156 evaluation Methods 0.000 title claims description 59
- 210000004027 cell Anatomy 0.000 claims description 88
- 230000008602 contraction Effects 0.000 claims description 52
- 210000000107 myocyte Anatomy 0.000 claims description 47
- 108010035532 Collagen Proteins 0.000 claims description 40
- 102000008186 Collagen Human genes 0.000 claims description 40
- 229920001436 collagen Polymers 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 32
- 230000004118 muscle contraction Effects 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 210000003205 muscle Anatomy 0.000 claims description 12
- 238000012258 culturing Methods 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 8
- 210000000130 stem cell Anatomy 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 6
- 239000002243 precursor Substances 0.000 claims description 5
- 230000001172 regenerating effect Effects 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 4
- 230000004956 cell adhesive effect Effects 0.000 claims description 2
- 230000009257 reactivity Effects 0.000 claims description 2
- 239000002131 composite material Substances 0.000 description 19
- 230000004069 differentiation Effects 0.000 description 13
- 230000000638 stimulation Effects 0.000 description 12
- 210000004748 cultured cell Anatomy 0.000 description 11
- 239000002609 medium Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000002363 skeletal muscle cell Anatomy 0.000 description 8
- 239000010410 layer Substances 0.000 description 6
- 210000003098 myoblast Anatomy 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 210000004413 cardiac myocyte Anatomy 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002027 skeletal muscle Anatomy 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 108010045569 atelocollagen Proteins 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000006938 muscular dystrophy Diseases 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000003969 blast cell Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000006203 ethylation Effects 0.000 description 1
- 238000006200 ethylation reaction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000000419 skeletal muscle satellite cell Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035322 succinylation Effects 0.000 description 1
- 238000010613 succinylation reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010247914A JP5549547B2 (ja) | 2010-11-04 | 2010-11-04 | 筋細胞の出力装置及び筋細胞の出力評価方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010247914A JP5549547B2 (ja) | 2010-11-04 | 2010-11-04 | 筋細胞の出力装置及び筋細胞の出力評価方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009066178A Division JP2015037381A (ja) | 2009-03-18 | 2009-03-18 | 筋細胞の出力装置及び筋細胞の出力評価方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011030574A JP2011030574A (ja) | 2011-02-17 |
| JP2011030574A5 JP2011030574A5 (enExample) | 2011-06-02 |
| JP5549547B2 true JP5549547B2 (ja) | 2014-07-16 |
Family
ID=43760265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010247914A Expired - Fee Related JP5549547B2 (ja) | 2010-11-04 | 2010-11-04 | 筋細胞の出力装置及び筋細胞の出力評価方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5549547B2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5544474B2 (ja) * | 2009-12-11 | 2014-07-09 | 国立大学法人東北大学 | 細胞検査用バイオアッセイ用キット |
| KR102305908B1 (ko) * | 2019-05-29 | 2021-09-28 | 숭실대학교산학협력단 | 미세유체 제어를 위한 바이오 엑츄에이터, 이의 조립방법, 미세유체 제어장치 및, 미세유체 제어방법 |
| CN120936703A (zh) | 2023-04-11 | 2025-11-11 | 住友电木株式会社 | 细胞特性检测用器件和细胞特性检测套组 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19500498C2 (de) * | 1995-01-10 | 1997-05-07 | Thomas Dr Med Eschenhagen | Matrixkörper für die Messung isometrischer Kraftparameter von Zellgewebe, Verfahren zum Herstellen des Matrixkörpers, Set für dieses Verfahren und Verwendung des Matrixkörpers zum Kultivieren von Kardiomyozyten |
| CA2497343C (en) * | 2001-08-14 | 2013-04-02 | Washington University In St. Louis | Systems and methods for screening pharmaceutical chemicals |
| WO2006113382A2 (en) * | 2005-04-15 | 2006-10-26 | Wake Forest University Health Sciences | Bioreactor system and method of enhancing functionality of muscle cultured in vitro |
| JP4758314B2 (ja) * | 2006-09-21 | 2011-08-24 | 学校法人常翔学園 | 骨格筋の培養用足場、同培養装置及び骨格筋の形成方法 |
-
2010
- 2010-11-04 JP JP2010247914A patent/JP5549547B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011030574A (ja) | 2011-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mueller et al. | Effects of external stimulators on engineered skeletal muscle tissue maturation | |
| Dennis et al. | Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines | |
| Pesce et al. | Cardiac fibroblasts and mechanosensation in heart development, health and disease | |
| Huyer et al. | Biomaterial based cardiac tissue engineering and its applications | |
| Moon et al. | Cyclic mechanical preconditioning improves engineered muscle contraction | |
| Tandon et al. | Electrical stimulation systems for cardiac tissue engineering | |
| WO2021041979A1 (en) | Method for intracellular delivery of compounds using cell force and shape with electric fields | |
| Okano et al. | Tissue engineered skeletal muscle: preparation of highly dense, highly oriented hybrid muscular tissues | |
| JPWO2016060260A1 (ja) | 組織片 | |
| US9506025B2 (en) | Cultured muscle produced by mechanical conditioning | |
| EP2766473A1 (en) | In vitro microphysiological system for high throughput 3d tissue organization and biological function | |
| KR20150036810A (ko) | 세포의 입체 구조체의 제조 방법 | |
| Chan et al. | Fabrication and characterization of optogenetic, multi-strip cardiac muscles | |
| US20160032234A1 (en) | Methods and devices for mechanical and electrical stimulation of stem cell monolayer and 3d cultures for tissue engineering applications | |
| WO2012048242A1 (en) | Anisotropic biological pacemakers and av bypasses | |
| Zhao et al. | Differential effects of directional cyclic stretching on the functionalities of engineered cardiac tissues | |
| Zhang et al. | Sinusoidal stretchable fibrous electrodes regulate cardiac contraction | |
| Cao et al. | Electrical and mechanical strategies to enable cardiac repair and regeneration | |
| JP5549547B2 (ja) | 筋細胞の出力装置及び筋細胞の出力評価方法 | |
| JP2015037381A (ja) | 筋細胞の出力装置及び筋細胞の出力評価方法 | |
| Fujita et al. | Novel method for measuring active tension generation by C2C12 myotube using UV‐crosslinked collagen film | |
| Solazzo et al. | A workflow to produce a low-cost in vitro platform for the electric-field pacing of cellularised 3D porous scaffolds | |
| JP6706948B2 (ja) | 細胞培養物およびその製造方法 | |
| JP6756502B2 (ja) | 細胞培養物およびその製造方法 | |
| US20240060052A1 (en) | Artificial Skeletal Muscle Tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110418 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110418 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110418 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120509 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130319 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130520 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140204 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140401 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140422 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140505 |
|
| R151 | Written notification of patent or utility model registration |
Ref document number: 5549547 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
| LAPS | Cancellation because of no payment of annual fees |